VAZCULEP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vazculep, and when can generic versions of Vazculep launch?
Vazculep is a drug marketed by Exela Pharma and is included in one NDA.
The generic ingredient in VAZCULEP is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vazculep
A generic version of VAZCULEP was approved as phenylephrine hydrochloride by HIKMA on December 20th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VAZCULEP?
- What are the global sales for VAZCULEP?
- What is Average Wholesale Price for VAZCULEP?
Summary for VAZCULEP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Patent Applications: | 1,869 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VAZCULEP |
What excipients (inactive ingredients) are in VAZCULEP? | VAZCULEP excipients list |
DailyMed Link: | VAZCULEP at DailyMed |
![VAZCULEP drug patent expirations Drug patent expirations by year for VAZCULEP](/p/graph/s/t/VAZCULEP-patent-expirations.png)
![Drug Prices for VAZCULEP](/p/graph/drug-price/VAZCULEP.png)
Pharmacology for VAZCULEP
Drug Class | alpha-1 Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha1-Agonists |
US Patents and Regulatory Information for VAZCULEP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exela Pharma | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-001 | Jun 27, 2014 | AP1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Exela Pharma | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-002 | Jun 27, 2014 | AP1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Exela Pharma | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-003 | Jun 27, 2014 | AP1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |